In the Life Sciences research space, investments in technology have historically lagged behind other industries. As a result, much of the current infrastructure is outdated and fragmented, making it challenging to keep up with breakthroughs in science and technology.
As part an effort to help solve this technology challenge, Accenture, Merck and Amazon Web Services (AWS) have entered a pre-competitive collaboration to launch a cloud-based informatics platform that aims to allow Life Sciences companies improve productivity, efficiency and innovation in the early stages of drug development. Merck will be the first company to use this ground-breaking platform.
Contract Pharma spoke with Brad Michel, managing director of Accenture Scientific Informatics Services to discuss the goals of the collaboration and the main obstacles the partnership aims to overcome. –KB
Co
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
